Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF-α and IL-23p19 bioactivities.
Wang J, Kang G, Lu H, de Marco A, Yuan H, Feng Z, Gao M, Wang X, Wang H, Zhang X, Wang Y, Zhang M, Wang P, Feng Y, Liu Z, Cao X, Huang H.
Wang J, et al. Among authors: wang x, wang h, wang y, wang p.
Clin Transl Med. 2024 Mar;14(3):e1636. doi: 10.1002/ctm2.1636.
Clin Transl Med. 2024.
PMID: 38533646
Free PMC article.